MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Using cognitive computing to identify existing drugs with potential to stabilize mitophagy pathways associated with Parkinson’s Disease

    N. Visanji, N. Moskal, G. Shi, A. Lacoste, S. Spangler, P. Lewis, A. Mcquibban (Toronto, ON, Canada)

    Objective: We applied IBM Watson for Drug Discovery (WDD), a cognitive computing platform that uses natural language processing, to identify compounds with the potential to…
  • 2019 International Congress

    INTREPID: A 2-Year Follow-Up of a Prospective, Double Blinded, Multi-Center Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant-Current Rechargeable System for Treatment of Parkinson’s Disease

    J. Vitek, R. Jain, L. Chen, I. Study Group, P. Starr (Minneapolis, MN, USA)

    Objective: The objective of the INTREPID clinical trial assessed improvement in motor function and quality of life in patients with advanced, levodopa responsive Parkinson's disease…
  • 2019 International Congress

    Successful Treatment of Orthostatic Tremor using Perampanel

    A. Wadhwa, S. Schaefer (New Haven, CT, USA)

    Objective: Orthostatic tremor is notoriously difficult to treat. To date, there has only been one case report of marked improvement of symptoms using perampanel. We present…
  • 2019 International Congress

    Treatment monitoring using objective and frequent digital testing in the D1PAM (LY3154207) phase 1B Parkinson’s disease clinical trial

    J. Wang, C. Battioui, Y. Li, A. Calvin, L. Wu, A. Romano, B. Miller (Indianapolis, IN, USA)

    Objective: This study evaluates the feasibility, reliability, and validity of smartphone app-based testing in patients with Parkinson’s disease (PD) in the D1PAM (D1 positive allosteric…
  • 2019 International Congress

    Impact of oral COMT-inhibitors on gut microbiota and biologically active microbial metabolites in patients with Parkinson’s Disease

    D. Grün, V. Zimmer, J. Kauffmann, M. Unger, J. Spiegel, KU. Dillmann, A. Schwiertz, K. Faßbender, M. Fousse (Homburg, Germany)

    Objective: To investigate if we were able to reproduce our previous findings in an independent patient cohort and whether such a correlation also exists in…
  • 2019 International Congress

    A Case Presentation of Wilson’s Disease

    D. Al Elwany, S. Ahmed, H. Deraz, C. Ragaey (Cairo, Egypt)

    Objective: To study clinical presentations of Wilson’s disease. Background: Wilson disease (WD; also known as hepatolenticular degeneration) is an autosomal-recessive disorder caused by mutation in…
  • 2019 International Congress

    Sex-specific effect of ATXN2 rs7969300 polymorphism on age at onset in Spinocerebellar Ataxia type 2

    L. Almaguer-Mederos, S. Gispert, D. Almaguer-Gotay, R. Aguilera-Rodríguez, Y. González-Zaldívar, Y. Vázquez-Mojena, D. Cuello-Almarales, D. Palenzuela, G. Auburger (Havana, Cuba)

    Objective: To assess the influence of SNP rs7969300 within ATXN2 locus on the age of onset in patients with Spinocerebellar Ataxia type 2. Background: It…
  • 2019 International Congress

    Survival estimates for Spinocerebellar Ataxia type 2 based on age at onset and CAG repeats length

    L. Almaguer-Mederos, R. Aguilera-Rodríguez, Y. González-Zaldívar, D. Almaguer-Gotay, D. Cuello-Almarales, Y. Vázquez-Mojena, L. Velásquez-Pérez (Holguín, Cuba)

    Objective: To obtain survival estimates for SCA2 patients based on the age at onset and CAG repeats length . Background: Spinocerebellar ataxia type 2 (SCA2)…
  • 2019 International Congress

    Ataxia by Mutation in CACNA1A Gene – Case Series

    P. Almeida, J. Pedroso, I. Brandi (Salvador, Brazil)

    Objective: The present study aim to describes 4 patients of the same family with ataxia and migraine. In 2 of them sequencing analysis was positive…
  • 2019 International Congress

    Dentatorubral-Pallidoluysian Atrophy outside of Asia: A case report of the first Austrian family harbouring this rare mutation

    M. Amprosi, W. Nachbauer, E. Indelicato, A. Eigentler, G. Puttinger, J. Gusenleitner, T. von Oertzen, S. Boesch (Innsbruck, Austria)

    Objective: To report clinical features of the first Austrian family with Dentatorubral-Pallidoluysian Atrophy (DRPLA). Background: DRPLA is a progressive disorder with an autosomal-dominant mode of…
  • « Previous Page
  • 1
  • …
  • 1215
  • 1216
  • 1217
  • 1218
  • 1219
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley